Sharon Townson insider trades
Open-market stock purchases and sales by Sharon Townson, Chief Scientific Officer at Monte Rosa Therapeutics, Inc, from SEC Form 4 filings since Mar 1, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 6, 2026 | GLUE Monte Rosa Therapeutics, Inc | Sold | $9.7K |
| Jul 6, 2026 | GLUE Monte Rosa Therapeutics, Inc | Sold | $130K |
| Jul 6, 2026 | GLUE Monte Rosa Therapeutics, Inc | Bought (not open market) | — |
| Jul 6, 2026 | GLUE Monte Rosa Therapeutics, Inc | Bought (not open market) | $36.8K |
| Jun 23, 2026 | GLUE Monte Rosa Therapeutics, Inc | Bought (not open market) | — |
| Jun 23, 2026 | GLUE Monte Rosa Therapeutics, Inc | Sold | $60K |
| Jun 17, 2026 | GLUE Monte Rosa Therapeutics, Inc | Sold | $57K |
| Jun 17, 2026 | GLUE Monte Rosa Therapeutics, Inc | Bought (not open market) | — |
| May 29, 2026 | GLUE Monte Rosa Therapeutics, Inc | Sold | $119K |
| May 29, 2026 | GLUE Monte Rosa Therapeutics, Inc | Bought (not open market) | — |
| Jan 5, 2026 | GLUE Monte Rosa Therapeutics, Inc | Sold | $47.9K |
| Jan 2, 2026 | GLUE Monte Rosa Therapeutics, Inc | Bought (not open market) | — |
| Jan 2, 2026 | GLUE Monte Rosa Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- GLUE Monte Rosa Therapeutics, Inc: 6 sales, last Jul 6, 2026